产品服务
信号通路
货号: FQ00004
货期: 现货
价格: 700/2400/5200
所属分类:
靶点: iNOS
应用: IHC-P, IF
反应性 : Human,Mouse,Rat
宿主物种 : Rabbit
偶联-Conjugate : Unconjugated
隐藏域元素占位
详细信息
组成 : PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
纯化工艺 : Protein A
储存 : 12 months from date of receipt / reconstitution, -20 °C as supplied
浓度 : 0.5 mg/ml
克隆性 : Monoclonal
抗原&靶点信息
基因名称 : NOS2
蛋白名称 : Nitric oxide synthase, inducible
别名 : inducible nitric oxide synthase, Hepatocyte NOS, HEP-NOS, Inducible NO synthase, NOS type II, NOS2
背景:
VEGF Receptor 2 (VEGFR-2), also known as KDR in humans and Flk-1 in mice, is a crucial receptor tyrosine kinase that plays a central role in angiogenesis, the formation of new blood vessels. This receptor has high affinity for VEGF-A and mediates most of the endothelial growth, migration, and survival signals induced by VEGF-A. Structurally, VEGFR-2 is a glycosylated transmembrane protein with a molecular weight of about 230 kDa, consisting of an extracellular domain (ECD) for ligand binding, a transmembrane domain (TMD), a juxtamembrane domain (JMD), a tyrosine kinase domain (TKD), and a C-terminal domain (CTD) for signaling. Upon binding to VEGF-A, VEGFR-2 undergoes dimerization and autophosphorylation, activating downstream signaling pathways such as the PLCγ-PKC-MAPK pathway, which promotes endothelial cell proliferation, migration, and vascular permeability. VEGFR-2 is widely expressed in vascular endothelial cells and is also found in some tumor cells, making it a key target for both pro-angiogenic therapies in conditions like ischemic diseases and anti-angiogenic therapies in cancer.


微信客服